Figure 3From: MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1 Kaplan-Meier curves for patients without a p53 mutation showing that time (months) to progression was shorter for those with abnormal (blue curve) p16 expression as compared to those with normal (green curve) p16 expression, although this difference was not statistically significant. (Log rank chi square 3.78, p = 0.052).Back to article page